Oxaliplatin and 5-FU/LV:The New Standard Treatment of Advanced Colorectal Cancer - CancerConnect
5-Fluorouracil (5-FU) resistance and the new strategy to enhance the sensitivity against cancer: Implication of DNA repair inhibition - ScienceDirect
Frontiers | 5-Fluorouracil: A Narrative Review on the Role of Regulatory Mechanisms in Driving Resistance to This Chemotherapeutic Agent
Curcumin Chemosensitizes 5-Fluorouracil Resistant MMR-Deficient Human Colon Cancer Cells in High Density Cultures | PLOS ONE
5‐Fluorouracil efficacy requires anti‐tumor immunity triggered by cancer‐cell‐intrinsic STING | The EMBO Journal
5‐Fluorouracil resistance mechanisms in colorectal cancer: From classical pathways to promising processes - Blondy - 2020 - Cancer Science - Wiley Online Library
5-FU Chemotherapy Drug To Treat Colon Cancer | Onco.com
Pharmacogenomics of 5-fluorouracil in colorectal cancer: review and update | SpringerLink
Overcoming acquired drug resistance in colorectal cancer cells by targeted delivery of 5-FU with EGF grafted hollow mesoporous silica nanoparticles - Nanoscale (RSC Publishing)
Over-expression of EGFR regulated by RARA contributes to 5-FU resistance in colon cancer - Figure f4 | Aging
Enhanced anti-colon cancer efficacy of 5-fluorouracil by epigallocatechin-3- gallate co-loaded in wheat germ agglutinin-conjugated nanoparticles - ScienceDirect
Over-expression of EGFR regulated by RARA contributes to 5-FU resistance in colon cancer - Figure f5 | Aging
DNA Mismatch Repair and 5-FU: What's the Connection? | Fight Colorectal Cancer
Generation and characterization of 5-FU resistant cells. A. Colon... | Download Scientific Diagram
![Microbial metabolite restricts 5-fluorouracil-resistant colonic tumor progression by sensitizing drug transporters via regulation of FOXO3-FOXM1 axis [Abstract]](https://www.thno.org/v12/p5574/toc.jpg "Microbial metabolite restricts 5-fluorouracil-resistant colonic tumor progression by sensitizing drug transporters via regulation of FOXO3-FOXM1 axis [Abstract]")
Microbial metabolite restricts 5-fluorouracil-resistant colonic tumor progression by sensitizing drug transporters via regulation of FOXO3-FOXM1 axis [Abstract]
Cancers | Free Full-Text | 5-Fluorouracil as a Tumor-Treating Field-Sensitizer in Colon Cancer Therapy
5-FU promotes stemness of colorectal cancer via p53-mediated WNT/β-catenin pathway activation | Nature Communications
5‐Fluorouracil resistance mechanisms in colorectal cancer: From classical pathways to promising processes - Blondy - 2020 - Cancer Science - Wiley Online Library
Downregulation of lncRNA CCAT1 enhances 5-fluorouracil sensitivity in human colon cancer cells | BMC Molecular and Cell Biology | Full Text
Hypoxic stress induces 5-FU chemoresistance in colon cancer cells. (A)... | Download Scientific Diagram
5-FU promotes stemness of colorectal cancer via p53-mediated WNT/β-catenin pathway activation | Nature Communications
Annexin A1 is involved in resistance to 5-FU in colon cancer cells
5-Fluorouracil (5-FU)-resistant colon cancer cells acquire resistance... | Download Scientific Diagram
Cancers | Free Full-Text | 5-Fluorouracil as a Tumor-Treating Field-Sensitizer in Colon Cancer Therapy
Wnt pathway is involved in 5-FU drug resistance of colorectal cancer cells | Experimental & Molecular Medicine
Targeting EGFR sensitizes 5-Fu-resistant colon cancer cells through modification of the lncRNA-FGD5-AS1-miR-330-3p-Hexokinase 2 axis: Molecular Therapy - Oncolytics
Levamisole and Fluorouracil for Adjuvant Therapy of Resected Colon Carcinoma | NEJM
